Stéphane Bancel - Wikipedia
He is the chief executive officer (CEO) of the American pharmaceutical and biotechnology company Moderna, known for its COVID-19 vaccine. Before joining Moderna, Bancel was the …
Leadership Team - Moderna
Stéphane Bancel has been Moderna's Chief Executive Officer since October 2011 and has served on Moderna’s board of directors since March 2011. Prior to joining Moderna, Mr. …
Did Moderna CEO 'Admit' to Making COVID-19 Vaccine Before …
断言: The CEO of Moderna "admitted" during the 2023 World Economic Forum meeting in Davos that the company was making a COVID-19 vaccine in January of 2020 "…
· 已被 snopes.com 证实Moderna - Wikipedia
In November 2024, Moderna Inc. announced that Stéphane Bancel, currently serving as Chief Executive Officer, will step down from his role as Chief Commercial Officer while continuing as …
Moderna CEO Bancel steps down as sales chief, Bloomberg News …
(Reuters) -Vaccine maker Moderna's (MRNA) chief executive officer Stephane Bancel will vacate his role as the company's chief commercial officer, Bloomberg News reported on Tuesday …
Stéphane Bancel - Forbes
4 天之前 · Stephane Bancel is the CEO of Cambridge, Massachusetts-based biotech firm Moderna, known for its Covid-19 vaccine. He became CEO of Moderna in 2011 and owns a …
Moderna Chief Executive Officer Stéphane Bancel Elected to …
Stéphane Bancel has served as Moderna's Chief Executive Officer since October 2011 and as a member of Moderna's board of directors since March 2011. In the 13 years since he joined …
Moderna CEO Bancel Steps Down as Sales Chief, Bloomberg …
2024年11月5日 · (Reuters) -Vaccine maker Moderna's chief executive officer Stephane Bancel will vacate his role as the company's chief commercial officer, Bloomberg News reported on …
Moderna Chief Executive Officer Stéphane Bancel Elected to …
2024年2月7日 · Stéphane Bancel has served as Moderna's Chief Executive Officer since October 2011 and as a member of Moderna's board of directors since March 2011. In the 13 years …
Meet the Moderna Team
Meet our executive team & Board of Directors who are committed to solving the world’s diseases with mRNA technology.